Tesaro Directors Slam 'Innuendo' In Del. Suit Over $5.1B Sale
A class of Tesaro stockholders seeking damages for an allegedly underpriced $5.1 billion sale of the cancer drugmaker in 2018 came to Chancery Court with a suit "heavy on innuendo and...To view the full article, register now.
Already a subscriber? Click here to view full article